Comprehensive Psychiatry
Volume 51, Issue 3 , Pages 293-297 , May 2010

Impact of obsessive-compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder

  • Ahmet Koyuncu

      Affiliations

    • Department of Psychiatry, Batı Bahat Hospital, İstanbul, Turkey
    • ,
  • Raşit Tükel

      Affiliations

    • Department of Psychiatry, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey
    • ,
  • İlker Özyıldırım

      Affiliations

    • Department of Psychiatry, Ünye State Hospital, Ordu, Turkey
    • Corresponding Author InformationCorresponding author. Ünye Devlet Hastanesi, Psikiyatri Birimi, Ünye, Ordu, Türkiye. Tel.: +90 5362853833; fax: +90 4523233336.
    • ,
  • Handan Meteris

      Affiliations

    • Department of Psychiatry, Erenköy State Hospital, İstanbul, Turkey
    • ,
  • Olcay Yazıcı

      Affiliations

    • Department of Psychiatry, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey

References 

  1. McElroy SL, Altshuler LL, Suppes T, Keck PEJ, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158:420–426
  2. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for BD (STEP-BD). Am J Psychiatry. 2004;161:2222–2229
  3. Tamam L, Ozpoyraz N. Comorbidity of anxiety disorder among patients with bipolar I disorder in remission. Psychopathology. 2002;35:203–210
  4. Pini S, Dell'Osso L, Mastrocinque C, Marcacci G, Papasogli A, Vignoli S, et al. Axis I comorbidity in bipolar disorder with psychotic features. Br J Psychiatry. 1999;175:467–471
  5. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27:1079–1089
  6. Young LT, Cooke RG, Robb JC, Levitt AJ, Joffe RT. Anxious and non-anxious bipolar disorder. J Affect Disord. 1993;29:49–52
  7. Zutshi A, Reddy YC, Thennarasu K, Chandrashekhar CR. Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2006;256:428–436
  8. Chen YW, Dilsaver SC. Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders. Psychiatry Res. 1995;59:57–64
  9. Kruger S, Cooke RG, Hasey GM, Jorna T, Persad E. Comorbidity of obsessive compulsive disorder in bipolar disorder. J Affect Disord. 1995;34:117–120
  10. Cassano GB, Pini S, Saettoni M, Dell'Osso L. Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry. 1999;156:474–476
  11. Henry C, Van den Bulke D, Bellivier F, Etain B, Rouillon F, Leboyer M. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry. 2003;64:331–335
  12. Vieta E, Colom F, Corbella B, Martinez-Aran A, Reinares M, Benabare A, et al. Clinical correlates of psychiatric comorbidity in bipolar I patients. Bipolar Disord. 2001;3:253–258
  13. Perugi G, Akiskal HS, Pfanner C, Presta S, Gemignani A, Milanfranchi A, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997;46:15–23
  14. Hantouche EG, Kochman F, Demonfaucon C, Barrot I, Öillet B, Lancrenon S, et al. Bipolar obsessive-compulsive disorder: confirmation of results of the “ABC-OCD” survey in 2 populations of patients members versus non member of an association. Encephale. 2002;28:21–28
  15. Feske U, Frank E, Mallinger AG, Houck PR, Fagiolini A, Shear MK, et al. Anxiety as a correlate of response to the acute treatment of bipolar I disorder. Am J Psychiatry. 2000;157:956–962
  16. Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS. Obsessive-compulsive–bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63:1129–1134
  17. American Psychiatry Association . Diagnostic and statistical manual of mental disorders. 4th text revision, ed.. Washington (DC): American Psychiatry Association; 2000;
  18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM–IV clinical version (SCID–I/CV). Washington DC: American Psychiatric Press; 1997;
  19. Freeman MP, Freeman SA, Susan L, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68:1–23
  20. Kruger S, Braunig P, Cooke RG. Comorbidity of obsessive-compulsive disorder in recovered inpatients with bipolar disorder. Bipolar Disord. 2000;2:71–74
  21. Perugi G, Frare F, Madaro D, Maremmani I, Akiskal HS. Alcohol abuse in social phobic patients: is there a bipolar connection?. J Affect Disord. 2002;68:33–39
  22. Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, et al. Obsessive compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord. 2004;78:175–183
  23. DePaulo JR, Simpson SG. Therapeutic and genetic prospects of an atypical affective disorder. J Clin Psychopharmacol. 1978;7(6 Suppl.):50S–54S
  24. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL. Obsessive-compulsive disorder and serotonin: is there a connection?. Biol Psychiatry. 1985;20:1174–1188
  25. Bellodi L. The heterogeneity of obsessive-compulsive disorder and its implications for treatment. In:  Maj M,  Sartorius N,  Okasha A,  Zohar J editor. Obsessive-Compulsive Disorder. Chichester: John Wiley & Sons; 2000;p. 76–79
  26. Go FS, Malley EE, Birmaher B, Rosenberg DR. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 1998;8:73–80
  27. Angst J. Comorbidity of anxiety, phobia, compulsion and depression. Int Clin Psychopharmacol. 1993;8:21–25
  28. Tukel R, Meteris H, Koyuncu A, Tecer A, Yazici O. The clinical impact of mood disorder comorbidity on obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci. 2006;256:240–245
  29. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R Psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19
  30. Szadoczky E, Papp ZS, Vitrai J, Rihmer Z, Furedi J. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J Affect Disord. 1998;50:153–162
  31. Akiskal HS. Classification, diagnosis and boundaries of bipolar disorders: a review. In:  Maj M,  Akiskal HS,  Lopez-Ibor JJ,  Sartorius N editor. Bipolar Disorder. West Sussex: John Wiley & Sons; 2002;p. 1–95
  32. Strober M, Carlson G. Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three–to four year prospective follow–up investigation. Arch Gen Psychiatry. 1982;39:549–555
  33. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J Affect Disord. 1983;5:112–115

PII: S0010-440X(09)00085-6

doi: 10.1016/j.comppsych.2009.07.006

Comprehensive Psychiatry
Volume 51, Issue 3 , Pages 293-297 , May 2010

Article Tools